Scar Prevention Clinical Trial
Official title:
Efficacy of a Soft Silicone Dressing to Prevent Scarring After Bilateral Total Knee Arthroplasty: A Randomized Paired Controlled Trial.
Verified date | March 2024 |
Source | Thammasat University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The goal of this RCT is comparing efficacy of silicone dressing in scar preventing after simultaneous bilateral total knee arthroplasty. The main question[s] it aims to answer are: - Does silicone dressing can prevent scar formation after total knee arthroplasty? - Does silicone dressing have similar functional outcomes and complications after total knee arthroplasty? Participants will apply silicone dressing after wound healed and apply for 10 weeks. Researchers will compare to the other side that is no intervention.
Status | Active, not recruiting |
Enrollment | 30 |
Est. completion date | May 31, 2024 |
Est. primary completion date | May 31, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years to 80 Years |
Eligibility | Inclusion Criteria: 1. Age between 50-80 years 2. The participant who undergo simultaneous bilateral total knee arthroplasty. 3. The participant can understand and give consent to participate in the project. Exclusion Criteria: 1. The participants had previous knee surgery 2. The participants have had a scar on the knee before getting the surgery. 3. Periprosthetic joint infection. 4. There are other complications of the surgical wound, such as split wound, thrombosis around the surgical wound. Abscess caused by stitches (stitch abscess) 5. Deep vein thrombosis (DVT) |
Country | Name | City | State |
---|---|---|---|
Thailand | Thammasat University | Khlong luang | Pathum Thani |
Lead Sponsor | Collaborator |
---|---|
Thammasat University Hospital |
Thailand,
Kong CG, Kim GH, Kim DW, In Y. The effect of topical scar treatment on postoperative scar pain and pruritus after total knee arthroplasty. Arch Orthop Trauma Surg. 2014 Apr;134(4):555-9. doi: 10.1007/s00402-014-1942-7. Epub 2014 Feb 9. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Vancouver Scar Scale | Vancouver Scar Scale evaluate by dermatologist (point) Range from 0-13 (0 mean best, 13 mean worst) | 6week, 3month, 6month, 1 year | |
Secondary | Range of motion | evaluate by long arm goniometer (degree) | 6week, 3month, 6month, 1 year | |
Secondary | Forgotten joint score | Forgotten joint score (point) (range 0-100, 0 mean worst, 100 mean best) | 6week, 3month, 6month, 1year | |
Secondary | modified WOMAC score | modified WOMAC score (point) (range 0-96, 0 mean best, 96 mean worst) | 6week, 3month, 6month, 1year | |
Secondary | Scar pain | evaluate by visual analog scale (point) (0-10, 0 mean best, 10 mean worst) | 6week, 3month, 6month, 1year | |
Secondary | Scar itching | evaluate by visual analog scale (point) (0-10, 0 mean best, 10 mean worst) | 6week, 3month, 6month, 1year | |
Secondary | Complications | Wound complication ex deep joint infection, surgical site infection, wound dehiscence | 6week, 3month, 6month, 1year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00892723 -
A Study to Evaluate the Safety and Efficacy of Additional Doses of AZX100 Drug Product Following Excision of Keloid Scars
|
Phase 2 | |
Completed |
NCT00825916 -
A Study to Evaluate the Safety and Efficacy of AZX100 Drug Product Following Excision of Keloid Scars
|
Phase 2 | |
Completed |
NCT01640912 -
Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109
|
Phase 1 | |
Completed |
NCT04707131 -
A Study of Single Ascending Dose of LEM-S401 in Healthy Participants
|
Phase 1 | |
Recruiting |
NCT04722705 -
Combined Intense Pulsed Light (IPL) With Fractional Erbium:YAG Laser Ablation in Scar Prevention
|
N/A | |
Terminated |
NCT01826942 -
Scar Prevention Using Fractional Carbon Dioxide Laser Treatment
|
N/A | |
Completed |
NCT00811577 -
A Phase 2a Study to Evaluate the Safety and Efficacy of AZX100 in Trocar Sites of Arthroscopic Shoulder Surgery Patients
|
Phase 2 | |
Completed |
NCT01037985 -
Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty
|
Phase 2 | |
Completed |
NCT01037413 -
Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast Surgery
|
Phase 2 | |
Completed |
NCT01780077 -
Evaluation of Safety, PK, and Preliminary Effects on Scar Formation of Multiple Intradermal Administrations of RXI-109
|
Phase 1 | |
Completed |
NCT01038297 -
Safety and Efficacy Study of Different Dose Levels of EXC 001 to Improve the Appearance of Scars in Subjects Undergoing Elective Abdominoplasty
|
Phase 2 |